Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes
and results in patches of depigmentation that are visible as white spots. Recent research …

The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held
back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at …

Background Vitiligo is a chronic autoimmune disease resulting in skin depigmentation and
reduced quality of life. There is no approved treatment for vitiligo repigmentation and current …

Importance References to the expected treatment response to phototherapy would be
helpful in the management of vitiligo because phototherapy requires long treatment …

The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …

Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown,
which usually occurs with asymptomatic whitish patch or macule. Although several …

Background There is currently no quantitative tool for evaluating vitiligo treatment response
using parametric methods. Objective To develop and apply a simple clinical tool, the Vitiligo …

Background Vitiligo is a chronic skin disorder characterised by patchy loss of skin colour.
Some people experience itching before the appearance of a new patch. It affects people of …

There are many obstacles to effective cancer chemotherapy, including drug penetration and
accumulation in tumors and drug systemic toxicity. The penetration of therapies into tumors …

Vitiligo is a common skin disorder characterized by immune‐mediated destruction of
melanocytes. Non‐segmental vitiligo, the most common clinical subtype, has usually a …